Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Price:
28.17
USD
-2.46%
Market Closed
Market Cap:
$13.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
HK |
|
S
|
Surana Telecom and Power Ltd
NSE:SURANAT&P
|
IN |
|
R
|
Resilient Energy Inc
OTC:RENI
|
US |
|
F3 Uranium Corp
OTC:FUUFF
|
CA |
|
X
|
Xinjiang Sayram Modern Agriculture Co Ltd
SSE:600540
|
CN |
|
S
|
Sentul City Tbk PT
XBER:5S4
|
ID |
|
N
|
Noodles & Co
F:NO3
|
US |
|
Epiroc AB
F:3AD2
|
SE |
|
O
|
OVB Holding AG
SWB:O4B
|
DE |
|
G
|
Global Uranium and Enrichment Ltd
ASX:GUE
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RGC.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RGC
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
RGC Competitors Multiples
Regencell Bioscience Holdings Ltd Competitors
Regencell Bioscience Holdings Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
13.9B USD | 0 | -3 886.4 | -3 723.2 | -3 693.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
